Market Overview:
The global topical hydrocortisone market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of skin diseases, rising awareness about skin care, and growing demand for over-the-counter (OTC) products. The global topical hydrocortisone market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into spray, ointment, and gel. The ointment segment is expected to dominate the global topical hydrocortisone market during the forecast period owing to its high usage in hospitals and dermatology clinics. On the basis of application, the hospital segment dominates this market owing to increased use of topical hydrocortisone products for treating various skin diseases in hospitals.
Product Definition:
Topical Hydrocortisone is a corticosteroid used to treat inflammation and itching. It is important because it can help relieve symptoms and speed up healing.
Spray:
Spray is a fine mist and it's used for the relief of redness, itching, and irritation caused by skin conditions like eczema. It also finds its use in treating insect bites, swelling from injury or inflammation & other external conditions. The main active ingredient present in spray is called hydrocortisone which has anti-inflammatory properties that help reduce the redness & swelling along with relieving itching sensation.
Ointment:
Ointment is a topical formulation used for the treatment of inflammatory skin conditions such as psoriasis, dermatitis and eczema. Topical hydrocortisone ointment is available in different forms including creams, gels and liquids which are applied to the affected areas. The ointments contain anti-inflammatory drugs that reduce redness, swelling & itching caused due to inflammation along with moisturizers that prevent further skin damage.
Application Insights:
Based on the application, the market is segmented into hospital, dermatology clinics, homecare and others. The hospital segment dominated the market in 2017 owing to increasing prevalence of skin conditions such as eczema and psoriasis among children. Furthermore, increasing number of burn cases due to scalds or chemical spillage drives topical hydrocortisone demand in hospitals for immediate treatment of burns.
The homecare application is projected to witness lucrative growth over the forecast period due to rising awareness about skin diseases among consumers globally. Consumers are opting for cost-effective drugs with high efficacy rates that can be used at home without any medical consultation or attendance by a doctor's prescription. This factor is anticipated to fuel topical hydrocortisone use inhome care applications over the next few years.
The dermatology clinics segment held a significant share owing to factors such as consumer preference for professional treatments along with regular visits by doctors treating various types of skin disorders including acne scars & marks.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players and well-established healthcare infrastructure. The region is expected to maintain its dominance over the forecast period, with U.S. being at the forefront. High awareness levels regarding diseases and their treatment options are some factors driving regional growth forward.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period due to increasing disposable income, rising population awareness about dermatology conditions, growing penetration of international topicals in local markets coupled with improving healthcare facilities & infrastructure in emerging countries such as China & India will drive regional growth over next eight years (2030). Moreover, favorable government initiatives for R&D activities related topical hydrocortisone products are also expected boost Asia Pacific’s market share during same period (2030).
Growth Factors:
- Increasing incidence of skin diseases: The global topical hydrocortisone market is expected to grow at a CAGR of 5.5% from 2016 to 2021, owing to the increasing incidence of skin diseases such as psoriasis, eczema, and dermatitis.
- Rising awareness about the benefits of topical hydrocortisone: There is a growing awareness among consumers about the benefits of using topical hydrocortisone for various skin conditions. This is likely to drive the growth of the global market in the coming years.
- Growing demand for over-the-counter (OTC) products: The demand for OTC products is rising due to their easy availability and affordability. This is expected to boost the growth prospects of the global topical hydrocortisone market in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Topical Hydrocortisone Market Research Report
By Type
Spray, Ointment, Gel
By Application
Hospital, Dermatology Clinics, Homecare, Others
By Companies
Pfizer, AstraZeneca, Sun Pharmaceutical Industries, Taro Pharmaceutical Industries, Merck, Actimis Pharmaceuticals, Siemens Healthcare, Sanofi, Novartis International, Eli Lilly, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Topical Hydrocortisone Market Report Segments:
The global Topical Hydrocortisone market is segmented on the basis of:
Types
Spray, Ointment, Gel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Dermatology Clinics, Homecare, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- AstraZeneca
- Sun Pharmaceutical Industries
- Taro Pharmaceutical Industries
- Merck
- Actimis Pharmaceuticals
- Siemens Healthcare
- Sanofi
- Novartis International
- Eli Lilly
- Pfizer
Highlights of The Topical Hydrocortisone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spray
- Ointment
- Gel
- By Application:
- Hospital
- Dermatology Clinics
- Homecare
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Topical Hydrocortisone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Topical hydrocortisone is a medication that is applied to the skin to treat conditions such as eczema, psoriasis, and dermatitis. It works by reducing inflammation and itching.
Some of the key players operating in the topical hydrocortisone market are Pfizer, AstraZeneca, Sun Pharmaceutical Industries, Taro Pharmaceutical Industries, Merck, Actimis Pharmaceuticals, Siemens Healthcare, Sanofi, Novartis International, Eli Lilly, Pfizer.
The topical hydrocortisone market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Topical Hydrocortisone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Topical Hydrocortisone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Topical Hydrocortisone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Topical Hydrocortisone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Topical Hydrocortisone Market Size & Forecast, 2018-2028
4.5.1 Topical Hydrocortisone Market Size and Y-o-Y Growth
4.5.2 Topical Hydrocortisone Market Absolute $ Opportunity
Chapter 5 Global Topical Hydrocortisone Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Topical Hydrocortisone Market Size Forecast by Type
5.2.1 Spray
5.2.2 Ointment
5.2.3 Gel
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Topical Hydrocortisone Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Topical Hydrocortisone Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Dermatology Clinics
6.2.3 Homecare
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Topical Hydrocortisone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Topical Hydrocortisone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Topical Hydrocortisone Analysis and Forecast
9.1 Introduction
9.2 North America Topical Hydrocortisone Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Topical Hydrocortisone Market Size Forecast by Type
9.6.1 Spray
9.6.2 Ointment
9.6.3 Gel
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Topical Hydrocortisone Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Dermatology Clinics
9.10.3 Homecare
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Topical Hydrocortisone Analysis and Forecast
10.1 Introduction
10.2 Europe Topical Hydrocortisone Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Topical Hydrocortisone Market Size Forecast by Type
10.6.1 Spray
10.6.2 Ointment
10.6.3 Gel
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Topical Hydrocortisone Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Dermatology Clinics
10.10.3 Homecare
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Topical Hydrocortisone Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Topical Hydrocortisone Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Topical Hydrocortisone Market Size Forecast by Type
11.6.1 Spray
11.6.2 Ointment
11.6.3 Gel
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Topical Hydrocortisone Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Dermatology Clinics
11.10.3 Homecare
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Topical Hydrocortisone Analysis and Forecast
12.1 Introduction
12.2 Latin America Topical Hydrocortisone Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Topical Hydrocortisone Market Size Forecast by Type
12.6.1 Spray
12.6.2 Ointment
12.6.3 Gel
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Topical Hydrocortisone Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Dermatology Clinics
12.10.3 Homecare
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Topical Hydrocortisone Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Topical Hydrocortisone Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Topical Hydrocortisone Market Size Forecast by Type
13.6.1 Spray
13.6.2 Ointment
13.6.3 Gel
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Topical Hydrocortisone Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Dermatology Clinics
13.10.3 Homecare
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Topical Hydrocortisone Market: Competitive Dashboard
14.2 Global Topical Hydrocortisone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 AstraZeneca
14.3.3 Sun Pharmaceutical Industries
14.3.4 Taro Pharmaceutical Industries
14.3.5 Merck
14.3.6 Actimis Pharmaceuticals
14.3.7 Siemens Healthcare
14.3.8 Sanofi
14.3.9 Novartis International
14.3.10 Eli Lilly
14.3.11 Pfizer
